$1.57
-0.12-7.10%
At close: -
$1.74
0.1710.83%
After Hours: 8:07 AM EDT
Comments
Loading...
Kairos Pharma (AMEX:KAPA) Stock, Earnings Estimates, EPS, And Revenue
Kairos Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.100
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Kairos Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Kairos Pharma (KAPA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Kairos Pharma (KAPA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Kairos Pharma (AMEX:KAPA) reporting earnings?
Kairos Pharma (KAPA) is scheduled to report earnings on February 23, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Kairos Pharma (AMEX:KAPA)?
The Actual EPS was $-0.10, which missed the estimate of $0.00.
What were Kairos Pharma’s (AMEX:KAPA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.